(1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.

Intensive Care Med · 2022 · PMC9273538 · PMID 35708758

Europe PMC DOI

hedged sentence

0.5200

closest p · 10.4× alpha

0.5200

boldest claim

The sentences

did not reach statistical significancep = 0.52not close (p > 0.1)

This was associated with higher per patient costs of antifungal therapy in the BDG (4451 €, IQR 1385–6923) compared to the control group (2800 €, IQR 989–7097) but this difference did not reach statistical significance ( p = 0.52).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.